Skip to content
Open access · OA via OpenAlex

Targeting BRD4 to reshape the inflammatory microenvironment of senescent bone marrow mesenchymal stem cells for improved hematopoietic stem cell transplantation reconstitution

Cong Wang, Chengyan Chai, Zheng Wang, Xi Zhang

Blood · 2025 · ▲ 1 citations

Abstract

Abstract Aims Chemotherapy-induced senescence(definition) of bone marrow mesenchymal stem cells (BMSCs) and concomitant hypersecretion of inflammatory factors are key factors driving hematopoietic microenvironment imbalance and impairing post-transplantation hematopoietic stem cell (HSC) reconstitution. This study aims to elucidate the regulatory mechanism of inflammatory factor expression in senescent BMSCs and explore a microenvironment-remodeling strategy via BRD4-targeted intervention. Methods We established an in vitro cell model for the induction of BMSCs' senescence by DNA-damaging drugs. Explore the mechanism through molecular intervention using siRNA, inhibitors, or senolytic drugs. And phenotypic analysis was conducted using qPCR, ELISA, and SA-β-gal staining methods. Functional validation was conducted through in vitro co-culture of senescent BMSCs with HSCs, followed by HSC colony-forming assays Results BRD4 knockdown significantly suppressed inflammatory factor transcription in senescent BMSCs . This phenomenon was recapitulated pharmacologically using the BRD4 inhibitor JQ1, which demonstrated dose-dependent suppression of senescence-associated secretory phenotype (SASP) factors. Crucially, dual-pathway intervention combining senolytic agents (dasatinib + quercetin, D+Q) with JQ1 exhibited synergistic efficacy, reducing SASP secretion more substantially than either monotherapy. Functional validation revealed that this combinatorial approach restored hematopoietic support capacity, with treated senescent BMSCs enhancing colony-forming units of co-cultured HSCs compared to untreated controls. Conclusion Our findings establish BRD4 as a critical regulator of chemotherapy-induced BMSC senescence and inflammatory factor expression. We further demonstrate that a novel dual-pathway strategy combining senescent cell clearance (via dasatinib + quercetin) with BRD4 inhibition synergistically restores the inflammatory hematopoietic microenvironment. This approach offers a promising therapeutic solution for improving post-transplantation HSC reconstitution, with BRD4-targeted interventions demonstrating significant potential for clinical translation.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1182/blood-2025-3184
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
Wang, C., Chai, C., Wang, Z., &amp; Zhang, X. (2025). Targeting BRD4 to reshape the inflammatory microenvironment of senescent bone marrow mesenchymal stem cells for improved hematopoietic stem cell transplantation reconstitution. <em>Blood</em>. https://doi.org/10.1182/blood-2025-3184
Vancouver
Wang C, Chai C, Wang Z, Zhang X. Targeting BRD4 to reshape the inflammatory microenvironment of senescent bone marrow mesenchymal stem cells for improved hematopoietic stem cell transplantation reconstitution. Blood. 2025. doi:10.1182/blood-2025-3184.
BibTeX
@article{cong2025Target, title = {Targeting BRD4 to reshape the inflammatory microenvironment of senescent bone marrow mesenchymal stem cells for improved hematopoietic stem cell transplantation reconstitution}, author = {Cong Wang and Chengyan Chai and Zheng Wang and Xi Zhang}, journal = {Blood}, year = {2025}, doi = {10.1182/blood-2025-3184}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings